When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - Blueprint's avapritinib OK'd in Europe for type of GI tract cancer
Blueprint Medicines Corporation
As expected, the European Commission approves Blueprint Medicines' ([[BPMC]] -0.7%) Ayvakyt (avapritinib) as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumors ((GIST)) harboring the platelet-derived growth factor receptor alpha ((PDGFRA)) D842V mutation.Two months ago, the advisory group CHMP adopted a positive opinion backing approval.